• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
788.00 -20 (-2.53%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    781.25

  • Today’s High

    818.05

  • Open

    814.00

  • Perv Close

    808.45

  • 52W Low

    636.10

  • 52W High

    853.50

Key Indicators

  • P/E(TTM)

    94.54

  • Mar.Cap (₹Cr.)

    16,449.76

  • Div & Yield %

    0.00

  • Book Value(₹)

    103.83

  • Debt-Equity Ratio

    -2.53

  • AGM Date

    01-Aug-2025

  • EPS

    8.31

  • P/E Ratio

    94.54

Financials Ratios

  • Debt-Equity Ratio

    1.00

  • Mar.Cap (₹Cr.)

    16,449.76

  • RONW (%)

    8.89

  • ROCE (%)

    10.46

Score Board

  • Equity (₹ in Cr.)

    20.88

  • BV (₹)

    103.80

  • Sales( ₹ in Cr.)

    1,642.05

  • NP (in Cr.)

    173.46

  • NP Var(%)

    82.0

  • Div%

    0.0

  • CPS (₹)

    14.30

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    16,399.66

  • 52 Week High

    853.50

  • 52 Week Low

    636.10

  • Price BSE

    786.0

  • Price NSE

    788.00

  • Market Capital( in Cr.)

    16,399.66

  • P/C Ratio

    54.80

  • P/E Ratio

    94.60

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,418.68 1,157.40 841.02 751.47 725.36 695.11
Other Income 29.33 27.96 28.15 27.29 17.84 5.63
Stock Adjustments -23.80 4.59 2.83 16.50 5.51 -0.58
Total Income 1,424.21 1,189.95 872.00 795.26 748.71 700.16
EXPENDITURE :            
Raw Materials 408.78 413.12 251.14 232.69 207.72 188.22
Power and Fuel Cost 49.49 43.73 31.86 27.25 27.04 25.36
Employee Cost 430.63 353.76 263.37 203.64 202.50 197.18
Other Manufacturing Expenses 84.73 90.06 78.21 50.32 48.82 46.81
Selling and Administration Expenses 117.15 84.16 84.59 85.45 67.36 54.53
Miscellaneous Expenses 16.06 10.29 9.79 4.44 7.57 7.75
Employee Benefit Expenses 430.63 353.76 263.37 203.64 202.50 197.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,106.84 995.11 718.97 603.79 561.01 519.85
Operating Profit 317.37 194.84 153.03 191.46 187.70 180.30
Interest 81.15 74.38 50.98 32.11 21.26 23.78
Gross Profit 236.22 120.46 102.05 159.35 166.44 156.52
Depreciation 107.21 87.77 79.70 71.77 52.36 44.26
Profit Before Tax 129.01 32.69 22.35 87.58 114.08 112.26
Current Tax 7.97 10.73 9.37 3.73 20.48 30.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 25.81 -2.28 -2.70 18.55 13.47 9.37
Reported Net Profit 95.23 24.24 15.68 65.30 80.14 72.90
Extraordinary Items 0.01 -0.38 11.31 0.00 0.00 0.02
Adjusted Net Profit 95.22 24.62 4.37 65.30 80.14 72.88
Adjustment below Net Profit 1.08 2.39 0.00 0.83 0.81 -0.28
P & L Balance brought forward 497.75 478.02 461.76 394.23 314.93 232.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 6.90 -0.58 -0.21 1.65 -9.94
P & L Balance carried down 594.05 497.75 478.02 460.57 394.23 314.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 383.30 396.30 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 38.33 39.63 0.00 0.00 0.00
Earnings Per Share-Unit Curr 53.92 13.76 8.93 36.65 48.92 44.54
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 572.37 517.79 507.50 486.92 484.05 437.47
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    35.15%

  • Public Share Holding

    64.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.69 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,611,290 2.21 4,611,290 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.37 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 53,961,920 25.88 53,961,920 4
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 69,773,115 33.46 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,399,524 14.58 30,399,524 98
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,219,995 2.50 5,219,995 5
Mutual Funds / UTI 39,050,215 18.73 39,050,215 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 861,715 0.41 861,715 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,531,449 36.22 75,531,449 127
2] Non Institution
Bodies Corporate 632,741 0.30 632,741 113
Clearing Members 27 0.00 27 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,721,405 3.70 7,667,002 905
Foreign Non Institution Other 34,846,957 16.71 34,846,957 2
Hindu Undivided Families 241,418 0.12 241,418 4,147
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,141,290 3.42 7,141,290 9
Individuals holding nominal share capital up to Rs. 1 lakh 6,544,488 3.14 6,539,488 121,059
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,669,352 0.80 1,669,352 3
Others 921,500 0.44 921,500 2
Sub Total 59,719,178 28.64 59,659,775 126,241
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 208,545,302 100.00 208,485,899 126,380

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Formulations

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    Runa Karan

  • Auditor

    BSR & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 785.60 1,448.01 1,418.68 94.54 11.36
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10